Noninvasive reconstruction of cardiac electrical activity: update on current methods, applications and challenges.
M J M Cluitmans, R L M Peeters, R L Westra...
https://pubmed.ncbi.nlm.nih.gov/25896779/Actively Recruiting
Led by XSpline S.p.A. · Updated on 2024-10-24
150
Participants Needed
13
Research Sites
26 weeks
Total Duration
Researchers are evaluating a method to improve Cardiac Resynchronization Therapy CRT implantation by using a cloud-based pre-procedural roadmap. This roadmap integrates 3D images from electrical activation sequences and coronary venous anatomy obtained by non-invasive tests. The study aims to see if this approach can guide the placement of the left ventricular lead to areas of delayed electrical activation and reduce the hearts left ventricular end-systolic volume by at least 15% in 75% of patients six months after treatment. Participants will undergo CRT implantation guided by XSpline technology, which uses patient data including ECG, echocardiography, and computed tomography angiography. The imaging data are processed on a cloud platform to identify the best site for lead placement. The procedure follows local protocols with visual verification by X-ray to confirm lead position. The study includes at least 150 patients and compares the new approachs outcomes to previous CRT populations. During the study, participants will have their clinical and cardiovascular history recorded along with routine examinations and imaging tests. Researchers will monitor heart function changes, procedural time, and total X-ray exposure over six months. The main outcome measured is the reduction in left ventricular end-systolic volume. Safety and feasibility of the XSpline platform use for CRT implantation will also be assessed.
CONDITIONS
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
C
Claudia M Amatruda, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
XSpline S.p.A.
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | CRT Device Implantation Guided by XSpline Platform | Standard CRT Implantation (Conventional Guidance) |
|---|---|---|
| What it is | CRT device implantation where the position of the LV lead is selected based on non-invasive electrical mapping and venous anatomy assessment using the XSpline software, in addition to routine clinical and imaging data. | CRT device implantation in which the LV lead position is chosen using standard clinical, ECG, echocardiographic, and imaging criteria, as recommended by international heart failure guidelines. |
| Role in trial | The XSpline approach is being evaluated as an investigational tool to enhance CRT lead placement and improve CRT response rates. | Represents the established guideline-based pathway for CRT without additional advanced software-based mapping. |
| Primary use | To guide CRT LV-lead implantation in eligible chronic heart failure patients to improve the chance of a positive CRT response. | To guide CRT LV-lead implantation using clinical and imaging criteria in line with guideline recommendations. |
| How it is given or performed | Participants undergo standard pre-procedural testing, ECG, echocardiography, and CT angiography. Imaging and electrical data are analyzed with XSpline software, which identifies the optimal LV-lead target zone before CRT device implantation. Implantation proceeds per local protocol, with XSpline guidance informing final LV-lead placement. | Participants receive CRT device implantation based on clinical assessment, 12-lead ECG, routine echocardiography, and available imaging. LV-lead position is chosen by the implanting team using current best practice, without XSpline software. |
| Evidence status | Currently undergoing clinical investigation; published evidence on XSpline for CRT lead placement is not yet established in peer-reviewed studies. | Established efficacy of CRT for appropriately selected patients with heart failure and LBBB is supported by multiple randomized trials and international guidelines. |
| Important limitations | XSpline-guided CRT lead selection is investigational, with procedural feasibility, workflow integration, and resulting patient outcomes still being assessed. | Even with guideline-based lead positioning, a substantial proportion of patients do not experience a full therapeutic response to CRT. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of device implantation
Participants undergo CRT device implantation guided by a non-invasive electrical and venous anatomy assessment using the XSpline platform. This includes routine clinical workup, imaging, data processing, and lead placement according to local protocols.
1 visit (in-person)
Duration - 6 months
Participants are monitored for outcomes including reduction of left ventricular end-systolic volume and procedural parameters at 6 months after CRT implantation.
Follow-up visits over 6 months as per clinical protocol
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
M J M Cluitmans, R L M Peeters, R L Westra...
https://pubmed.ncbi.nlm.nih.gov/25896779/Charulatha Ramanathan, Raja N Ghanem, Ping Jia...
https://pubmed.ncbi.nlm.nih.gov/15034569/Simone Pezzuto, Frits W Prinzen, Mark Potse...
https://pubmed.ncbi.nlm.nih.gov/33241411/Michael Glikson, Jens Cosedis Nielsen, Mads Brix Kronborg...
https://pubmed.ncbi.nlm.nih.gov/34455430/Michele Brignole, Angelo Auricchio, Gonzalo Baron-Esquivias...
https://pubmed.ncbi.nlm.nih.gov/23801822/XSpline S.p.A.
Lead Sponsor